enGene Holdings (ENGN)

• Market cap: $358M
• 1 day: -14.64%
• 5 days: -29%
• 1 month: -26.26%
• 3 months: 84.95%
• 6 months: 75.96%
• Year to date: -2.55%
• 1 year: -10.18%
• 5 years: -65.6%
• 10 years: -65.6%
• Sector: Healthcare
• Industry: Biotechnology

About: enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Employees: 57